title: Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature review.
abstract: The first objective of radical prostatectomy is cancer control. However, the success of RP should be also measured by the long-term morbidity outcomes and by the maintenance of quality of life. We performed a review of the literature for combined results of continence, erectile function, and cancer control after radical prostatectomy. Since 2003 and the first report of "trifecta," only 7 series have yet reported such combined results (trifecta rate range: 20%-76%). The preoperative risk (D'Amico) predicted for quality of life outcomes and biochemical recurrence is an aggregate endpoint, the trifecta.
authors.affiliation: INSERM, Unit 955 EQ7, Department of Urology APHP, CHU Henri Mondor, Créteil, France.
authors.forename: Evanguelos
authors.initials: E
authors.lastname: Xylinas
authors.forename: Guillaume
authors.initials: G
authors.lastname: Ploussard
authors.forename: Xavier
authors.initials: X
authors.lastname: Durand
authors.forename: Alexandre
authors.initials: A
authors.lastname: de La Taille
authors.forename: Norman
authors.initials: N
authors.lastname: Gillion
authors.forename: Yves
authors.initials: Y
authors.lastname: Allory
authors.forename: Dimitri
authors.initials: D
authors.lastname: Vordos
authors.forename: Andras
authors.initials: A
authors.lastname: Hoznek
authors.forename: Claude Clément
authors.initials: CC
authors.lastname: Abbou
authors.forename: Laurent
authors.initials: L
authors.lastname: Salomon
mesh_terms: D006801:Humans; D008297:Male; D010410:Penile Erection; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000097:blood / Q000601:surgery*; D011788:Quality of Life; D016896:Treatment Outcome; D014554:Urination
chemical_list: D017430:Prostate-Specific Antigen